Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve

<div>A bubble chart classification of the KEGG pathway analysis and the linking protein-protein interaction network between the KLP-treated group and the DOR group. (a) The bubble size shows the number of DEPs associated with each GO and KEGG term. (b) The red bubbles represent upregulated proteins, and the blue bubbles represent downregulated protein.</div>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 

Figure 7 | Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 